527 related articles for article (PubMed ID: 28733083)
1. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors.
Jin XY; Chen H; Li DD; Li AL; Wang WY; Gu W
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):955-972. PubMed ID: 31072147
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.
Liu MC; Yang SJ; Jin LH; Hu DY; Xue W; Song BA; Yang S
Eur J Med Chem; 2012 Dec; 58():128-35. PubMed ID: 23124210
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.
Hua SX; Huang RZ; Ye MY; Pan YM; Yao GY; Zhang Y; Wang HS
Eur J Med Chem; 2015 May; 95():435-52. PubMed ID: 25841199
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity evaluation of novel ursolic acid derivatives.
Meng YQ; Zhang LF; Liu DY; Liu LW; Zhang Y; Zhao MJ
J Asian Nat Prod Res; 2016; 18(3):280-8. PubMed ID: 26524942
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety.
Ragab FAF; Abou-Seri SM; Abdel-Aziz SA; Alfayomy AM; Aboelmagd M
Eur J Med Chem; 2017 Sep; 138():140-151. PubMed ID: 28667871
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and screening of ursolic acid-benzylidine derivatives as potential anti-cancer agents.
Dar BA; Lone AM; Shah WA; Qurishi MA
Eur J Med Chem; 2016 Mar; 111():26-32. PubMed ID: 26854375
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents.
El Mansouri AE; Oubella A; Mehdi A; AitItto MY; Zahouily M; Morjani H; Lazrek HB
Bioorg Chem; 2021 Mar; 108():104558. PubMed ID: 33358270
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and anticancer activity of novel nopinone-based thiosemicarbazone derivatives.
Wang Y; Gu W; Shan Y; Liu F; Xu X; Yang Y; Zhang Q; Zhang Y; Kuang H; Wang Z; Wang S
Bioorg Med Chem Lett; 2017 Jun; 27(11):2360-2363. PubMed ID: 28431878
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.
Bajaj S; Kumar MS; Tinwala H; Yc M
Bioorg Chem; 2021 Jun; 111():104873. PubMed ID: 33845381
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
Vyas VK; Variya B; Ghate MD
Eur J Med Chem; 2014 Jul; 82():385-93. PubMed ID: 24929289
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel heteroarylmethylcarbamodithioates as potent anticancer agents: Synthesis, structure-activity relationship analysis and biological evaluation.
Li YB; Yan X; Li RD; Liu P; Sun SQ; Wang X; Cui JR; Zhou DM; Ge ZM; Li RT
Eur J Med Chem; 2016 Apr; 112():217-230. PubMed ID: 26900655
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative assay of 1,3,4-oxadiazole and 1,2,4-triazole derivatives in cancer cells.
Tu G; Yan Y; Chen X; Lv Q; Wang J; Li S
Drug Discov Ther; 2013 Apr; 7(2):58-65. PubMed ID: 23715503
[TBL] [Abstract][Full Text] [Related]
17. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiproliferative evaluation of 6-aryl-11-iminoindeno[1,2-c]quinoline derivatives.
Tseng CH; Tzeng CC; Chung KY; Kao CL; Hsu CY; Cheng CM; Huang KS; Chen YL
Bioorg Med Chem; 2011 Dec; 19(24):7653-63. PubMed ID: 22079254
[TBL] [Abstract][Full Text] [Related]
19. Optimization of activity localization of quinoline derivatives: Design, synthesis, and dual evaluation of biological activity for potential antitumor and antibacterial agents.
Jin G; Li Z; Xiao F; Qi X; Sun X
Bioorg Chem; 2020 Jun; 99():103837. PubMed ID: 32299019
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
